Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study.
about
Neuroinflammation and psychiatric illnessPersonalized medicine in major depressive disorder -- opportunities and pitfallsIs there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive DisorderNeuroinflammation and comorbidities are frequently ignored factors in CNS pathologyDeveloping biomarkers in mood disorders research through the use of rapid-acting antidepressantsNeurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidenceRole of neuroinflammation in neurodegenerative diseases (Review)Serum BDNF levels in relation to illness severity, suicide attempts, and central serotonin activity in patients with major depressive disorder: a pilot study.Proteomic Approaches to Enable Point-of-Care Testing and Personalized Medicine for Psychiatric Disorders.The Bipolar Illness Onset study: research protocol for the BIO cohort study.A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkersBiomarkers for depression: recent insights, current challenges and future prospects.Serum proteins mediate depression's association with dementiaThe diagnosis of depression: current and emerging methods.Blood transcriptomic biomarkers in adult primary care patients with major depressive disorder undergoing cognitive behavioral therapy.Testing the predictive value of peripheral gene expression for nonremission following citalopram treatment for major depression.Proteomic analysis of serum from patients with major depressive disorder to compare their depressive and remission statuses.Biomarkers in mood disorders research: developing new and improved therapeutics.Review of quantitative phase-digital holographic microscopy: promising novel imaging technique to resolve neuronal network activity and identify cellular biomarkers of psychiatric disorders.Discovery of blood transcriptomic markers for depression in animal models and pilot validation in subjects with early-onset major depression.Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA).The establishment of the objective diagnostic markers and personalized medical intervention in patients with major depressive disorder: rationale and protocol.Blood diagnostic biomarkers for major depressive disorder using multiplex DNA methylation profiles: discovery and validationAnterior cingulate cortex choline levels in female adolescents with unipolar versus bipolar depression: a potential new tool for diagnosisSerum proteomic profiling of major depressive disorder.A support vector machine model provides an accurate transcript-level-based diagnostic for major depressive disorder.Gene expression-based biological test for major depressive disorder: an advanced study.The consequences of DSM-5 for psychiatric diagnosis and psychopharmacotherapy.Imaging the pathophysiology of major depressive disorder - from localist models to circuit-based analysis.Blood-based biomarkers in depression: emerging themes in clinical research.Perfusion deficits, inflammation and aging precipitate depressive behaviour.DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences--part 1: general aspects and paradigmatic discussion of depressive disorders.Biomarker approaches in major depressive disorder evaluated in the context of current hypotheses.The promise of biomarkers in diagnosing major depression in primary care: the present and future.The emergence of point-of-care blood-based biomarker testing for psychiatric disorders: enabling personalized medicine.Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response.Personalized medicine in psychiatry.A longitudinal study of neurotrophic, oxidative, and inflammatory markers in first-onset depression in midlife women.Convergence Science Arrives: How Does It Relate to Psychiatry?Integrative transcriptomic meta-analysis of Parkinson's disease and depression identifies NAMPT as a potential blood biomarker for de novo Parkinson's disease.
P2860
Q21245244-91344BAE-99A1-4D67-9064-62F67E7BD028Q24170133-19769EDA-C444-4662-A4EA-ED63B0F8A7EDQ26747511-D8CA85D6-CEDD-437E-9BBB-E37D9C76BDD5Q26775794-79055027-7499-4DB3-888E-63EFD6350EBAQ26996955-E1E8F754-E8EE-4498-8792-57FD795F099AQ26999061-3DA82C5D-5C46-4A60-B3AE-84B6BCADC8A0Q28080292-333926B4-DEF7-499D-9C44-8CE7DA212B5AQ30441204-8607FA86-CCDF-454B-A513-BA497954DD35Q33453747-52CB8A5C-5C09-4898-BC59-6CFCEEFCBEF7Q33455222-166CA897-102D-429F-A92D-23CE9C96CD62Q33587452-2D90C8AE-9817-4F0E-A4BF-7174ED6D9088Q33704099-399EDC4B-658E-40F5-9A75-239DECA38AACQ33778209-4587FD45-F186-4DA9-B1F4-B18BF3999B1BQ33887233-29213251-165F-4231-A095-71972F46CDC0Q34345609-56DDC37C-0E2C-47AA-9EEA-B6A8512D9BD3Q34906947-65598476-9B36-41B6-B446-C0CD74CFDE87Q35330622-5D42F113-0727-4734-AB01-601740DCF5F8Q35735694-1418625D-4E48-4DFD-AF4E-B92DBFFF1B54Q35775099-B99B2852-81B0-4B2B-9EDD-827BFF71A5ACQ35913907-636378C6-0B16-4644-B0F3-63DCEBC40047Q36032426-B68F95D1-7B29-4F0A-BBE1-85BFE45BB773Q36079041-A6C30D83-D8E8-4E6D-91AA-5DB1E9C5988FQ36214173-A38F6F9F-8B68-4604-8EFE-1A8310638B54Q36424652-2CCE6AC6-B4E9-4D05-B3E0-E1F48FA8103AQ37347574-07BD99AD-33B8-4416-9BCF-C900D50095EBQ37622651-6A9A3DAE-7861-4EBD-B0B9-63A6E501FEBFQ37669886-ACF899AD-99A3-4242-B5A4-E7C396C89073Q38185094-8BDF33B5-C798-4E18-93DA-ACA0E692F329Q38194251-18456A72-11C4-42A7-9B7E-6621A4C285C3Q38219783-E8B16B45-5900-4522-A75C-957A33053F6FQ38230661-458C45B0-0F52-4E74-B174-A865D3E26A19Q38239554-C78C9438-16F7-42CC-8720-3FCFCF7E18E7Q38366733-F4D2AAA0-EF61-4C7E-ABE2-ED3B164FE63BQ38529746-D8CED02E-8116-451B-AB1F-A8ADB6F92038Q38783299-8D41BDD3-DBCF-4164-A7A9-EE90F75D9D2DQ38823641-2DAB94ED-3957-458B-9362-EEE3585E93EBQ38937776-4A26CD64-22A6-4D6F-A692-B82860F83839Q39307553-46AACD88-8AD2-4705-98BD-26D777890309Q41213108-EB4C4A0F-83CB-40D1-86AF-E7C8085D6A38Q41215282-4E8C8CDE-4EB4-4A27-981C-0B34E2DAC735
P2860
Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Assessment of a multi-assay, s ...... a pilot and replication study.
@en
Assessment of a multi-assay, s ...... a pilot and replication study.
@nl
type
label
Assessment of a multi-assay, s ...... a pilot and replication study.
@en
Assessment of a multi-assay, s ...... a pilot and replication study.
@nl
prefLabel
Assessment of a multi-assay, s ...... a pilot and replication study.
@en
Assessment of a multi-assay, s ...... a pilot and replication study.
@nl
P2093
P2860
P356
P1433
P1476
Assessment of a multi-assay, s ...... a pilot and replication study.
@en
P2093
G I Papakostas
J A Bilello
L Thurmond
R C Shelton
S H Lipkin
P2860
P2888
P304
P356
10.1038/MP.2011.166
P407
P577
2011-12-13T00:00:00Z